Pilot study for appropriate anti-infective community therapy. Effect of a guideline-based strategy to optimize use of antibiotics.
OBJECTIVE
To determine whether a community-wide, multi-intervention educational strategy (CoMPLI model) could enhance adoption of clinical guidelines and improve the use of antibiotics.


METHODS
Before-after trial using baseline and study periods with a control group.


METHODS
A small community in central Ontario.


METHODS
Health professionals, the general public, and the pharmaceutical industry.


METHODS
The educational strategy (CoMPLI), carried out during 6 winter months, consisted of continuing medical education sessions for health professionals and pharmaceutical representatives and a parallel public education campaign that included town hall meetings and pamphlets distributed by local pharmacists. The two main messages were: do not use antibiotics for viral respiratory infections, and use drugs recommended in the publication, Anti-infective Guidelines for Community-Acquired Infections.


METHODS
Total number of antibiotic claims and adjusted odds ratios (OR) were used to measure the likelihood of physicians prescribing first- or second-line agents compared with the previous year and compared with control physicians.


RESULTS
Claims in the study community decreased by nearly 10% during the 6-month study period compared with the baseline period from the previous year. Study physicians were 29% less likely (OR-1 = 0.71, range 0.67 to 0.76) to prescribe second-line antibiotics during the study period than physicians in the rest of the province.


CONCLUSIONS
Physicians participating in the pilot study were more likely to follow drug recommendations outlined in published guidelines.
Stewart
J
J
Medical Associates of Port Perry, Ont.
Pilla
J
J
Dunn
L
L
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy; D003627:Data Interpretation, Statistical; D011307:Drug Prescriptions; D006801:Humans; D016017:Odds Ratio; D009864:Ontario; D010865:Pilot Projects; D017410:Practice Guidelines as Topic; D012141:Respiratory Tract Infections / Q000188:drug therapy; D014777:Virus Diseases / Q000188:drug therapy
D000900:Anti-Bacterial Agents